Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 12:54 PM IST
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    Alkem Labs gets 2 USFDA observations for Daman facility

    Alkem Labs gets 2 USFDA observations for Daman facility

    Medical Dialogues Bureau31 Aug 2019 12:32 PM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received two observations from the US health regulator for...
    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Medical Dialogues Bureau31 Aug 2019 9:30 AM IST
    Alimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Medical Dialogues Bureau30 Aug 2019 2:57 PM IST
    These intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Medical Dialogues Bureau29 Aug 2019 4:10 PM IST
    New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Farhat Nasim27 Aug 2019 2:30 PM IST
    "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Medical Dialogues Bureau27 Aug 2019 10:00 AM IST
    As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    Medical Dialogues Bureau27 Aug 2019 9:45 AM IST
    Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 2:23 PM IST
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    Alkem Labs gets 4 USFDA observations for St Louis facility

    Alkem Labs gets 4 USFDA observations for St Louis facility

    Medical Dialogues Bureau26 Aug 2019 12:39 PM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Medical Dialogues Bureau26 Aug 2019 9:45 AM IST
    New Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
    GSK Belantamab Mafodotin shows to help blood cancer patients

    GSK Belantamab Mafodotin shows to help blood cancer patients

    Medical Dialogues Bureau26 Aug 2019 9:15 AM IST
    Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok